mounjaro retatrutide Ozempic, Mounjaro, Retatrutide: The Disease Your Labs Miss (Pathologist Explains) Retatrutide: The New Triple-Agonist Weight

In December 2023, the European Medicines Agencys Pharmacovigilance Risk Assessment Committee announced an update on its review of GLP-1 RAs and suicidal thoughts and thoughts of self-harm, which began in July 2023

The GLP-1 agonists that are currently approved for weight loss are liraglutide (Saxenda) and semaglutide (Wegovy)

You will likely get the most from Pep if you: Use an Android phone or a mix of devices

A recent study using 233 million patient records found significantly lower depression and anxiety scores for patients that were treated with GLP-1s, particularly with tirzepatide

Some of them are starting to look interesting

Many of these are approved for the treatment of type 2 diabetes, and some are approved for weight loss